Center of excellence

Zevra Therapeutics Completes Acquisition of Acer Therapeutics in its Journey to Become a Leading Rare Disease Company

Retrieved on:

Monday, November 20, 2023

NPC, Sale, Physician, LLP, FDA, Form, Acquisition, Transaction, Disease, Therapy, William Blair & Company, Center of excellence, Business development, Syndrome, Pillsbury Winthrop Shaw Pittman, Prospectus, Niemann–Pick disease, Patient, Pharmaceutical industry

CELEBRATION, Fla., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a rare disease therapeutics company, today announced the completion of its acquisition of Acer Therapeutics Inc. (Acer) which marks a significant step forward in executing Zevra’s strategy to become a leader in developing and commercializing treatments for rare diseases and furthers the Company’s commitment to supporting patient communities with limited or no existing therapeutic options. As previously announced on August 31, 2023, the capital-efficient transaction included approximately 2.96 million shares of Zevra stock and contingent value rights (CVRs) issued in exchange for all outstanding shares of Acer. The CVRs represent the right to receive up to $76 million payable upon the achievement of certain regulatory and net sales milestones, net of the amount payable, if any, to SWK Funding LLC, a former warrantholder of Acer. In addition, immediately prior to the signing and announcement of the merger agreement, Zevra purchased Acer’s senior secured debt for a combination of cash, Zevra stock and notes valued at $28.5 million as a condition of entering into the merger agreement with Acer.

Key Points:

“Today’s acquisition marks an exciting milestone for Zevra as we advance our mission to deliver therapies to the rare disease community,” said Neil F. McFarlane, President and Chief Executive Officer of Zevra.
The acquisition brings complementary assets and bolsters Zevra’s commercial and development capabilities with the addition of key Acer personnel and existing commercial systems.
“Acer’s programs and capabilities are an excellent fit for Zevra, particularly OLPRUVA for UCDs, which is a serious rare genetic metabolic disorder.
Pillsbury Winthrop Shaw Pittman LLP served as legal advisor to Acer, and William Blair & Company, LLC served as exclusive financial advisor to Acer.

GlobalLogic Announces Acquisition of Mobiveil

Retrieved on:

Tuesday, December 19, 2023

The acquisition also brings marquee client relationships and provides GlobalLogic with immediate access to a substantial skilled talent pool relevant to the industry.

Key Points:

The acquisition also brings marquee client relationships and provides GlobalLogic with immediate access to a substantial skilled talent pool relevant to the industry.
We’re excited to welcome Mobiveil into the GlobalLogic family and look forward to writing the next chapter in the industry together."
This acquisition offers Mobiveil the opportunity to become part of GlobalLogic’s unique culture, and to expand our capabilities and collaborate on new, innovative projects.
We look forward to leveraging this partnership to deliver cutting-edge solutions and elevate our industry impact.”
Three co-founders of Mobiveil, Ravi Thummarukudy, Gopa Periyadan and Srinivasan Duraiswamy, will join the GlobalLogic Leadership team.

Carrum Health and Florida Cancer Specialists & Research Institute Partner on Breast Cancer Treatment Model

Retrieved on:

Friday, December 22, 2023

Partnership, Cancer, Carrum, Victoria, Center of excellence, FCS, Patient, Radiation, Health insurance

FORT MYERS, Fla., Dec. 22, 2023 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) announced today a new partnership with Carrum Health, a value-based Centers of Excellence healthcare solution changing how cancer and surgical care are paid for and delivered, to provide high-quality, cost-effective breast cancer care to patients at FCS. Through employers, Carrum Health will offer patients a bundled package for breast cancer care that includes two years of coverage for treatment, which may comprise chemotherapy, radiation, and symptom management from FCS.

Key Points:

Through employers, Carrum Health will offer patients a bundled package for breast cancer care that includes two years of coverage for treatment, which may comprise chemotherapy, radiation, and symptom management from FCS.
The partnership will focus on patients with non-metastatic breast cancer in Florida.
In return, employers who have aligned with Carrum Health will benefit from the advanced oncology treatment options offered at the nearly 100 FCS locations across Florida.
FCS and Carrum plan to expand this collaboration to other cancers over time, enabling access for more Floridians to benefit from high-value cancer care.

SourceFuse Ends 2023 with Remarkable Growth

Retrieved on:

Tuesday, December 19, 2023

Graviton, AWS, Software, CMO, Entrepreneurship, Infrastructure as code, Center of excellence, ARC, Migration

JACKSONVILLE, Fla., Dec. 19, 2023 /PRNewswire/ -- SourceFuse, a strategic digital transformation company helping businesses evolve through cloud-native technologies, today announces another successive year of phenomenal growth and new company values. Already skilled at integrating AI/ML and advanced analytics across its offerings, SourceFuse is well-positioned to ensure its clients continue to benefit from opportunities presented by genAI.

Key Points:

JACKSONVILLE, Fla., Dec. 19, 2023 /PRNewswire/ -- SourceFuse, a strategic digital transformation company helping businesses evolve through cloud-native technologies, today announces another successive year of phenomenal growth and new company values.
SourceFuse's achievements in 2023 featured a substantial 40% increase in revenue, 72% renewal business, and 45% increase in customer base.
"Our marketing activities during 2023 were grounded in innovation and a deep understanding of our audience," added Vaidant Singh , CMO at SourceFuse.
In 2023, SourceFuse introduced Infrastructure as Code (IaC) in ARC by SourceFuse , accelerating infrastructure deployment and CI/CD by 35% faster than industry benchmarks.

SourceFuse Ends 2023 with Remarkable Growth

Retrieved on:

Tuesday, December 19, 2023

Graviton, AWS, Software, CMO, Infrastructure as code, Center of excellence, ARC, Migration

JACKSONVILLE, Fla., Dec. 19, 2023 /PRNewswire/ -- SourceFuse, a strategic digital transformation company helping businesses evolve through cloud-native technologies, today announces another successive year of phenomenal growth and new company values. Already skilled at integrating AI/ML and advanced analytics across its offerings, SourceFuse is well-positioned to ensure its clients continue to benefit from opportunities presented by genAI.

Key Points:

JACKSONVILLE, Fla., Dec. 19, 2023 /PRNewswire/ -- SourceFuse, a strategic digital transformation company helping businesses evolve through cloud-native technologies, today announces another successive year of phenomenal growth and new company values.
SourceFuse's achievements in 2023 featured a substantial 40% increase in revenue, 72% renewal business, and 45% increase in customer base.
"Our marketing activities during 2023 were grounded in innovation and a deep understanding of our audience," added Vaidant Singh , CMO at SourceFuse.
In 2023, SourceFuse introduced Infrastructure as Code (IaC) in ARC by SourceFuse , accelerating infrastructure deployment and CI/CD by 35% faster than industry benchmarks.

Trinity Life Sciences Institutes a Formal Cell and Gene Therapy Center of Excellence

Retrieved on:

Monday, December 18, 2023

Trinity Life Sciences , a leader in global life sciences commercialization solutions, introduces a Cell & Gene Therapy (C&GT) Center of Excellence (COE) that supports life sciences companies in successfully commercializing a C&GT asset.

Key Points:

Trinity Life Sciences , a leader in global life sciences commercialization solutions, introduces a Cell & Gene Therapy (C&GT) Center of Excellence (COE) that supports life sciences companies in successfully commercializing a C&GT asset.
View the full release here: https://www.businesswire.com/news/home/20231218899992/en/
Keren Shani, Head of Cell & Gene Therapy at Trinity Life Sciences, speaks with a colleague after an exhilarating strategy session in June 2023.
An on-demand webinar, Gene Therapy Uptake: The Elephant in the Room , evaluates the factors that are unique to forecasting gene therapy markets and discusses what companies need to know to maximize their revenue potential.
Among other topics, viewers will hear potential pricing strategies to consider—as well as key market drivers and product factors contributing to gene therapy opportunity.

Christopher M. Pieczonka, M.D., Named CEO of Associated Medical Professionals of NY, an Affiliate of U.S. Urology Partners

Retrieved on:

Wednesday, December 13, 2023

Associated Medical Professionals of NY is a leading multi-specialty practice spanning 19 locations in Central New York, including ten offices and nine hospitals.

Key Points:

Associated Medical Professionals of NY is a leading multi-specialty practice spanning 19 locations in Central New York, including ten offices and nine hospitals.
is an affiliate of U.S. Urology Partners , one of the largest independent providers of urological and specialty related services in the nation, which is backed by NMS Capital .
Corina Tracy, Chief Executive Officer of U.S. Urology Partners , stated, “I am excited to announce that Dr. Christopher Pieczonka has assumed the role of Chief Executive Officer of Associated Medical Professionals of NY.
, stated, “I am both honored and humbled to take on the new role of CEO of Associated Medical Professionals.

Ingram Micro Empowers Channel Partners to Innovate, Grow and Create More Value with AWS

Retrieved on:

Monday, December 11, 2023

Both awards recognize Ingram Micro for playing a key role in helping channel partners worldwide accelerate success and move businesses to AWS through all phases of complex migration projects, including discovery, planning, migration, and operations.

Key Points:

Both awards recognize Ingram Micro for playing a key role in helping channel partners worldwide accelerate success and move businesses to AWS through all phases of complex migration projects, including discovery, planning, migration, and operations.
Ingram Micro navigates AWS partners through APN programs while also expanding their services capabilities including assessment, design, deployment, and management of cloud migrations with greater speed.
Other designations include the AWS Cloud Management Tools (CMT) Competency, the AWS DevOps Consulting Competency, and the AWS Config Service Delivery designation.
“The support we’ve received technically, commercially, and via programs has added invaluable strength to our company.”
For more information about Ingram Micro and AWS, visit here .

inTEST Continues Executing on Five-Point Strategy to Expand Geographically - Establishes Southeast Asia Center of Excellence in Malaysia

Retrieved on:

Wednesday, December 6, 2023

Other Defense, Contracts, General Automotive, Technology, Automotive, Defense, Semiconductor, Other Manufacturing, Automotive Manufacturing, Aerospace, Manufacturing, Telecommunications, NYSE, Engineering, Videology, ITS, Growth, Center of excellence

Nick Grant, President and CEO, commented, “A key element of our 5-Point Strategy for growth is geographic expansion.

Key Points:

Nick Grant, President and CEO, commented, “A key element of our 5-Point Strategy for growth is geographic expansion.
We are most successful at winning new customers through hands-on demonstration of our products and showcasing our engineering capabilities.
It will serve as the main location in the region for customer product demonstrations, customer service and applications training.
Currently, Asia–Pacific represents approximately 35% of revenue for the Company primarily from customers based in the U.S.

Introducing Astrion, a Transformative Evolution of Oasis Systems and ERC

Retrieved on:

Tuesday, December 5, 2023

Astrion brings together two flagship government services firms, Oasis Systems and ERC, with a combined 60-year legacy of dedicated service, proven results, and mission success.

Key Points:

Astrion brings together two flagship government services firms, Oasis Systems and ERC, with a combined 60-year legacy of dedicated service, proven results, and mission success.
Astrion embraces a forward-thinking spirit to tackle critical challenges across cybersecurity, digital solutions, mission support, and systems engineering to support the Air Force, Army, Civilian Agencies, Navy, and Space.
The Company unites over 2,800 employees serving customers across the U.S. with Centers of Excellence in Washington, DC; Huntsville, AL; and Burlington, MA.
With a focus on optimizing security programs, creating and managing comprehensive digital systems, providing specialized mission support services and delivering systems engineering and integration solutions, Astrion drives exemplary customer results.